The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rifadin 100 mg/5 ml Oral Suspension



Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/066/004

Main Information

Trade NameRifadin 100 mg/5 ml Oral Suspension
Active SubstancesRifampicin
Dosage FormOral suspension
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/066/004

Group Information

ATC CodeJ04AB Antibiotics
J04AB02 rifampicin

Status

License statusAuthorised
Licence Issued23/02/1977
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back